-
22 Benefits Of C B D Oil: Based On Academic Research
Market news
Health CanalOctober 15, 2020
The FDA recently recommended[1] the approval of Epidiolex, this recommendation by the FDA marked an official turn in the long-standing fight to legalize cannabis-derived medicines and products.
-
About CPhI & P-MEC China Virtual Expo Connect
Market news
PharmaSources.comMay 07, 2020
Boost your business online @ CPhI & P-MEC China Virtual Expo Connect For the first time ever, CPhI & P-MEC China will embrace virtual technology in order to quickly adapt to market changes and needs.
-
Eisai and Cogstate Expand Agreement for Global Development and Commercialization of Digital Cognitive Assessment Technologies
Market news
prnasiaOctober 26, 2020
Eisai Co., Ltd. and Cogstate, Ltd. announced that the companies have entered into a collaboration whereby Eisai has secured the global development rights and exclusive commercialization rights of all cognitive function tests developed by Cogstate ...
-
Canada's Prime Minister, Justin Trudeau, Announced Precision NanoSystems Will Receive $18.2 Million from the Government of Canada to Develop an RNA Vaccine for COVID-19
Market news
prnewswireOctober 26, 2020
Precision Nanosystems, Inc. (PNI), a global leader in technologies and solutions in genetic medicine, announced that it has received a commitment of up to $18.2 million in support from the Government of Canada under the Innovation, Science and ...
-
EffRx Pharmaceuticals signs exclusive license agreement with Diurnal for registration and commercialisation of Alkindi
Market news
pharmaceutical-business-reviewOctober 26, 2020
EffRx Pharmaceuticals SA announced it has recently entered into an exclusive license agreement with Diurnal Group plc for the registration and commercialization of Alkindi for pediatric adrenocortical insufficiency (AI) in Switzerland.
-
Aspirin could protect patients from severe COVID-19 complications
Market news
europeanpharmaceuticalreviewOctober 26, 2020
A study has shown that aspirin use was associated with a 47 percent decrease in the risk of dying in the hospital from COVID-19.
-
NICE recommends Keytruda (pembrolizumab) for treatment of HNSCC
Market news
europeanpharmaceuticalreviewOctober 26, 2020
NICE has recommended pembrolizumab for the treatment of metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC).
-
ICR urges change as NICE rejects Keytruda plus chemotherapy
Market news
pharmatimesOctober 26, 2020
The Institute for Cancer Research (ICR) has called for change in the way immunotherapy drugs are researched and evaluated after the National Institute for Health and Care Excellence (NICE) handed MSD’s Keytruda plus chemotherapy a rejection.
-
BMS partners with Sensyne Health for rare blood disease research
Market news
pharmatimesOctober 26, 2020
Clinical AI company Sensyne Health has signed a research collaboration agreement with Bristol Myers Squibb to apply machine learning for rare blood disease research.
-
Merck KGaA, IAVI and Serum Institute link up to develop COVID-19 mAbs
Market news
pharmatimesOctober 26, 2020
German pharma company Merck KGaA has partnered with non-profit scientific research organisation IAVI and Serum Institute of India to develop monoclonal antibodies (mAbs) for COVID-19.
Pharma Sources Insight